These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1235351)

  • 1. [Polycardiographic evaluation of the cardiotoxicity of adriamycin].
    Villani F; Beretta G; Guindani A; Pagnoni A; Vivarelli S
    G Ital Chemioter; 1975; 22(1-2):39-46. PubMed ID: 1235351
    [No Abstract]   [Full Text] [Related]  

  • 2. Doxorubicin (Adriamycin) cardiotoxicity.
    Weisburst MR; Pearlman ES; Capone RJ
    Conn Med; 1980 Mar; 44(3):133-6. PubMed ID: 7363615
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiodynamic effects during acute adriamycin administration].
    Mazzola C; Berardinelli P; Clini V; Cavallaro GF
    G Ital Chemioter; 1975; 22(1-2):33-8. PubMed ID: 1235350
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary phase I study of 4'-epi-adriamycin.
    Bonfante V; Bonadonna G; Villani F; Di Fronzo G; Martini A; Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):915-8. PubMed ID: 455333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin].
    Okuma K; Furuta I; Ota K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):502-8. PubMed ID: 6703724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related adriamycin cardiotoxicity in children.
    Pratt CB; Ransom JL; Evans WE
    Cancer Treat Rep; 1978 Sep; 62(9):1381-5. PubMed ID: 356987
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
    Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ
    Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Status of adriamycin in cancer therapy].
    Berndt H
    Arch Geschwulstforsch; 1982; 52(7):585-96. PubMed ID: 7165492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adriamycin cardiotoxicity in man.
    Rinehart JJ; Lewis RP; Balcerzak SP
    Ann Intern Med; 1974 Oct; 81(4):475-8. PubMed ID: 4277990
    [No Abstract]   [Full Text] [Related]  

  • 10. A clinicopathologic analysis of adriamycin cardiotoxicity.
    Lefrak EA; Pitha J; Rosenheim S; Gottlieb JA
    Cancer; 1973 Aug; 32(2):302-14. PubMed ID: 4353012
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of cardiotoxicity in new anthracycline analog ME 2303. ME 2303 Study Group].
    Okuma K; Ariyoshi Y; Wakui A; Ogawa M; Furue H; Niitani H; Shimoyama M; Majima H; Taguchi T; Kimura I
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1143-9. PubMed ID: 2053773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serial echocardiographic evaluation of the cardiotoxicity of adriamycin and therapeutic protocols].
    Villecco AS; Cagnano R; De Liberali E; Ferrari G; Musacchio M; Di Paolo E
    Cardiologia; 1985 May; 30(5):395-9. PubMed ID: 3833352
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adriamycin, cardiotoxicity--a case report].
    Okuma K; Ota K
    Gan To Kagaku Ryoho; 1982 May; 9(5):936-41. PubMed ID: 6307186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of doxorubicin cardiotoxicity by the bispiperazinedione ICRF-187 in women with advanced breast cancer: a preliminary report.
    Jurga L; Misurová E; Vancík J
    Neoplasma; 1993; 40(4):259-62. PubMed ID: 8272153
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiotoxicity due to prolonged administration of THP (2"R-4'-O-tetrahydropyranyl-adriamycin)].
    Suzuki M; Hirono M; Majima H
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1993-9. PubMed ID: 9350248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serial echocardiographic evaluation of subjects treated with adriamycin].
    Messina L; Palmieri S; Bonnì G; D'Alessandro N; Rausa L; Raineri A
    Boll Soc Ital Cardiol; 1981; 26(12):2231-7. PubMed ID: 7185392
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiotoxicity of adriamycin].
    Mordeglia F; Mirassou C
    Medicina (B Aires); 1979; 39(3):423-5. PubMed ID: 514062
    [No Abstract]   [Full Text] [Related]  

  • 18. Noninvasive cardiac evaluation of patients receiving adriamycin.
    Ewy GA; Jones SE; Friedman MJ; Gaines J; Cruze D
    Cancer Treat Rep; 1978 Jun; 62(6):915-22. PubMed ID: 667868
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of acute cardiotoxicity of anti-cancer agents-- analysis using Holter ECG monitoring].
    Okuma K; Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1893-900. PubMed ID: 3164181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD)].
    Adam Z; Elbl L; Vorlícek J; Hájek R; Tomíska M; Hejlová N; Králová E; Novotná H
    Vnitr Lek; 1994 Aug; 40(8):506-12. PubMed ID: 7941437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.